indirubin
Small moleculeexperimental
Indirubin is a chemical compound most often produced as a byproduct of bacterial metabolism. For instance, it is one of the compounds responsible for the generally benign condition purple urine bag syndrome, resulting from bacteria metabolizing indoxyl sulfate found naturally in urine. — Wikipedia
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2012 (NCT01735864)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Loading structure…
SMILES
O=C1Nc2ccccc2/C1=C1/Nc2ccccc2C1=O- Mol. weight
- 262.27 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaIndirubin ↗
- ChEMBLCHEMBL1276127 ↗
Also known as
- indigo red
- indirubin
- indirubin
- indirubin
- indirubin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01735864 | N/A | Nov 1, 2012 | Chang Gung University, Government of Taiwan |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chang Gung University | Academic/Hospital | 1 | 1 | 1 | 2012 |
| Government of Taiwan | Government | 1 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1